Table 3. Frequency of short-term newborn outcomes in each study group.
| Adverse outcome | Number of newborns completing evaluation | MATERNAL PTB GROUPS | P value | ||
|---|---|---|---|---|---|
| No-IAI | Yes-IAI | PE | |||
| IVH (grades 1–4) † | 372 | ||||
| Present | 15 (11) | 25 (22) | 13 (10) | 0.024 | |
| Absent | 116 (89) | 91 (78) | 112 (90) | ||
| NEC (grades 2–4) † | 372 | ||||
| Present | 7 (5) | 14 (12) | 4 (3) | 0.017 | |
| Absent | 124 (95) | 102 (88) | 121 (97) | ||
| PVL † | 371 | ||||
| Present | 4 (3) | 4 (3) | 3 (2) | 0.888 | |
| Absent | 126 (97) | 112 (97) | 122 (98) | ||
| BPD † | 349 | ||||
| Present | 14 (13) | 19 (18) | 20 (19) | 0.320 | |
| Absent | 110 (87) | 89 (82) | 97 (81) | ||
| ROP (grades 1–4) † | 371 | ||||
| Present | 13 (10) | 38 (33) | 28 (22) | <0.001 | |
| Absent | 117 (90) | 78 (67) | 97 (78) | ||
| Fetal and neonatal death † | 378 | ||||
| Present | 7 (5) | 10 (9) | 14 (11) | 0.283 | |
| Absent | 124 (95) | 106 (91) | 117 (89) | ||
| EONS † | 371 | ||||
| Present | 19 (15) | 51 (44) | 22 (18) | <0.001 | |
| Absent | 112 (85) | 65 (56) | 102 (82) | ||
| Confirmed EONS † | 372 | ||||
| Present | 5 (4) | 5 (4) | 2 (2) | 0.440 | |
| Absent | 126 (96) | 111 (96) | 123 (98) | ||
| Confirmed LOS † | 361 | ||||
| Present | 10 (8) | 30 (28) | 29 (23) | <0.001 | |
| Absent | 118 (92) | 78 (72) | 96 (77) | ||
† Data presented as n (%) and analyzed by Chi square tests.
Abbreviations: IVH, intra-ventricular hemorrhage; NEC, necrotizing enterocolitis; PVL, periventricular leukomalacia; BPD, bronchopulmonary dysplasia; ROP, retinopathy of prematurity; PTB, preterm birth; IAI, intra-amniotic inflammation/infection; PE, preeclampsia, EONS, early-onset neonatal sepsis; LOS, late-onset sepsis